Russia to join international medical device single audit program; pilot due in Australia, Brazil, Canada and US
This article was originally published in SRA
Executive Summary
Russia has signaled it will join the medical device single audit program (MDSAP) that international regulators are developing to streamline the oversight of manufacturing facilities and which is set to undergo a pilot in Australia, Brazil, Canada and the US1,2.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Moment Of Truth For Seven EU Filings; Cytokinetics To Make Its Case For Heart Failure Drug
The CHMP, the European Medicines Agency’s human medicines committee, will this week decide whether a range of new medicines merit being approved.
EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions
After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.